- Ensure adherence to the necessary U.S. quality standards.
- Work to precision and accuracy standards that are acknowledged worldwide.
- Check test findings against established benchmarks.
- Create and verify internal standards, specifications, and operating procedures.
- Hasten the development and approval of new products.
- Pharmaceuticals: both prescription and over-the-counter medications
- Products made using biology and biotechnology
- Blood and its derivatives
- Mixed-up preparations
- Cosmetics
- Nutritional supplements
- Excipients and other medication components
- Medical equipment
- Healthcare gases
- Health libraries
- Pharmacies
- Medical and pharmacy schools
- Drugs for animals
- Each general chapter has a unique number that is displayed in brackets next to the chapter name (for example, chromatography).
- General chapters may include the following:
- Tests and processes for applications through individual monographs,
- Practices and conditions for pharmaceutical compounding: Specifications and Descriptions,
- information generally used to interpret commendation criteria,
- General information for manufacturers of official substances or official goods, including a description of available pharmaceutical storage, dispensing, and packaging practices.
- The acceptance criteria can be supplied after the large intestine when the general chapter is mentioned in the monograph.
〈1〉 Injections and Implanted Drug Products (Parenterals)—Product Quality Tests | | 〈481〉 Riboflavin Assay |
〈2〉 Oral Drug Products—Product Quality Tests | | 〈501〉 Salts of Organic Nitrogenous Bases |
〈3〉 Topical and Transdermal Drug Products—Product Quality Tests | | 〈503.1〉 Trifluoroacetic Acid (TFA) in Peptides |
〈4〉 Mucosal Drug Products—Product Quality Tests | | 〈503〉 Acetic Acid in Peptides |
〈5〉 Inhalation and Nasal Drug Products—General Information and Product Quality Tests | | 〈507〉 Protein Determination Procedures |
〈7〉 Labeling | | 〈509〉 Residual DNA Testing |
〈11〉 USP Reference Standards | | 〈511〉 Single-Steroid Assay |
〈17〉 Prescription Container Labeling | | 〈525〉 Sulfur Dioxide |
〈31〉 Volumetric Apparatus | | 〈531〉 Thiamine Assay |
〈41〉 Balances | | 〈541〉 Titrimetry |
〈51〉 Antimicrobial Effectiveness Testing | | 〈551〉 Vitamin E Assay |
〈55〉Biological Indicators—Resistance Performance Tests | | 〈561〉 Articles of Botanical Origin |
〈56〉 Methods for Determination of Resistance of Microorganisms to Sterilization Processes | | 〈563〉 Identification of Articles of Botanical Origin |
〈60〉 Microbiological Examination of Nonsterile Products Tests for Burkholderia Cepacia Complex | | 〈565〉 Botanical Extracts |
〈61〉 Microbiological Examination of Nonsterile Products Microbial Enumeration Tests | | 〈571〉 Vitamin A Assay |
〈62〉 Microbiological Examination of Nonsterile Products Tests for Specified Microorganisms | | 〈580〉 Vitamin C Assay |
〈63〉 Mycoplasma Tests | | 〈581〉 Vitamin D Assay |
〈64〉 Probiotic Tests | | 〈591〉 Zinc Determination |
〈71〉 Sterility Tests | | 〈601〉 Inhalation and Nasal Drug Products Aerosols, Sprays, and Powders—Performance Quality Tests |
〈81〉 Antibiotics—Microbial Assays | | 〈602〉 Propellants |
〈85〉 Bacterial Endotoxins Test | | 〈603〉 Topical Aerosols |
〈87〉 Biological Reactivity Tests, In Vitro | | 〈604〉 Leak Rate |
〈88〉 Biological Reactivity Tests, In Vivo | | 〈607〉 Pharmaceutical Foams—Product Quality Tests |
〈89.1〉 Collagenase I | | 〈610〉 Alternative Microbiological Sampling Methods for Nonsterile Inhaled and Nasal Products |
〈89.2〉 Collagenase II | | 〈611〉 Alcohol Determination |
〈89〉 Enzymes Used as Ancillary Materials in Pharmaceutical Manufacturing | | 〈616〉 Bulk Density and Tapped Density of Powders |
〈90〉 Fetal Bovine Serum—Quality Attributes and Functionality Tests | | 〈621〉 Chromatography |
〈91〉 Calcium Pantothenate Assay | | 〈630〉 Visual Comparison |
〈92〉 Growth Factors and Cytokines Used in Cell Therapy Manufacturing | | 〈631〉 Color and Achromicity |
〈111〉 Design and Analysis of Biological Assays | | 〈641〉 Completeness of Solution |
〈115〉 Dexpanthenol Assay | | 〈643〉 Total Organic Carbon |
〈121.1〉 Physicochemical Analytical Procedures for Insulins | | 〈644〉 Conductivity of Solutions |
〈121〉 Insulin Assays | | 〈645〉 Water Conductivity |
〈123〉 Glucagon Bioidentity Tests | | 〈651〉 Congealing Temperature |
〈124〉 Erythropoietin Bioassays | | 〈659〉 Packaging and Storage Requirements |
〈126〉 Somatropin Bioidentity Test | | 〈660〉 Containers—Glass |
〈126〉 Somatropin Bioidentity Tests | | 〈661.1〉 Plastic Materials of Construction |
〈127〉 Flow Cytometric Enumeration of CD34+ Cells | | 〈661.2〉 Plastic Packaging Systems For Pharmaceutical Use |
〈129〉 Analytical Procedures for Recombinant Therapeutic Monoclonal Antibodies | | 〈661〉 Plastic Packaging Systems and Their Materials Of Construction |
〈151〉 Pyrogen Test | | 〈665〉 Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products and Biopharmaceuticals Drug Substances and Products |
〈161〉 Medical Devices—Bacterial Endotoxin and Pyrogen Tests | | 〈670〉 Auxiliary Packaging Components |
〈162〉 Diphtheria Antitoxin Potency Testing for Human Immune Globulins | | 〈671〉 Containers—Performance Testing |
〈165〉 Prekallikrein Activator | | 〈695〉 Crystallinity |
〈171〉 Vitamin B12 Activity Assay | | 〈696〉 Characterization of Crystalline Solids by Microcalorimetry and Solution Calorimetry |
〈181〉 Identification—Organic Nitrogenous Bases | | 〈697〉 Container Content for Injections |
〈191〉 Identification Tests—General | | 〈698〉 Deliverable Volume |
〈193〉 Identification—Tetracyclines | | 〈699〉 Density of Solids |
〈197〉 Spectroscopic Identification Tests | | 〈701〉 Disintegration |
〈198〉 Nuclear Magnetic Resonance Spectroscopy Identity Testing of Bacterial Polysaccharides Used in Vaccine Manufacture | | 〈705〉 Quality Attributes of Tablets Labeled as Having A Functional Score |
〈201〉 Thin-Layer Chromatographic Identification Test | | 〈711〉 Dissolution |
〈202〉 Identification of Fixed Oils By Thin-Layer Chromatography | | 〈721〉 Distilling Range |
〈203〉 High-Performance Thin-Layer Chromatography Procedure for Identification of Articles of Botanical Origin | | 〈724〉 Drug Release |
〈206〉 Aluminum | | 〈729〉 Globule Size Distribution in Lipid Injectable Emulsions |
〈207〉 Test for 1,6-Anhydro Derivative for Enoxaparin Sodium | | 〈730〉 Plasma Spectrochemistry |
〈208〉 Anti-Factor Xa and Anti-Factor IIa Assays for Unfractionated and Low Molecular Weight Heparins | | 〈731〉 Loss on Drying |
〈209〉 Low Molecular Weight Heparin Molecular Weight Determinations | | 〈733〉 Loss on Ignition |
〈210〉 Monosaccharide Analysis | | 〈735〉 X-Ray Fluorescence Spectrometry |
〈211〉 Arsenic | | 〈736〉 Mass Spectrometry |
〈212〉 Oligosaccharide Analysis | | 〈741〉 Melting Range or Temperature |
〈221〉 Chloride and Sulfate | | 〈755〉 Minimum Fill |
〈223〉 Dimethylaniline | | 〈761〉 Nuclear Magnetic Resonance Spectroscopy |
〈226〉 4-Epianhydrotetracycline | | 〈771〉 Ophthalmic Products—Quality Tests |
〈227〉 4-Aminophenol in Acetaminophen-Containing Drug Products | | 〈776〉 Optical Microscopy |
〈228〉 Ethylene Oxide and Dioxane | | 〈781〉 Optical Rotation |
〈232〉 Elemental Impurities—Limits | | 〈782〉 Vibrational Circular Dichroism Spectroscopy |
〈233〉 Elemental Impurities—Procedures | | 〈785〉 Osmolality and Osmolarity |
〈241〉 Iron | | 〈786〉 Particle Size Distribution Estimation by Analytical Sieving |
〈251〉 Lead | | 〈787〉 Subvisible Particulate Matter in Therapeutic Protein Injections |
〈261〉 Mercury | | 〈788〉 Particulate Matter in Injections |
〈267〉 Porosimetry by Mercury Intrusion | | 〈789〉 Particulate Matter in Ophthalmic Solutions |
〈268〉 Porosity by Nitrogen Adsorption–Desorption | | 〈790〉 Visible Particulates in Injections |
〈271〉 Readily Carbonizable Substances Test | | 〈791〉 pH |
〈281〉 Residue on Ignition | | 〈795〉 Pharmaceutical Compounding—Nonsterile Preparations |
〈291〉 Selenium | | 〈797〉 Pharmaceutical Compounding—Sterile Preparations |
〈301〉 Acid-Neutralizing Capacity | | 〈800〉 Hazardous Drugs—Handling in Healthcare Settings |
〈311〉 Alginates Assay | | 〈801〉 Polarography |
〈313〉 Molecular Weight and Polymer Chain Length Determination for Polypropylene Glycol Fatty Ethers | | 〈811〉 Powder Fineness |
〈341〉 Antimicrobial Agents—Content | | 〈821〉 Radioactivity |
〈345〉 Assay for Citric Acid Citrate and Phosphate | | 〈823〉 Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses |
〈351〉 Assay for Steroids | | 〈825〉 Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging |
〈381〉 Elastomeric Components in Injectable Pharmaceutical Product Packaging Delivery Systems | | 〈831〉 Refractive Index |
〈382〉 Elastomeric Component Functional Suitability in Parenteral Product Packaging Delivery Systems | | 〈841〉 Specific Gravity |
〈391〉 Epinephrine Assay | | 〈846〉 Specific Surface Area |
〈401〉 Fats and Fixed Oils | | 〈852〉 Atomic Absorption Spectroscopy |
〈411〉 Folic Acid Assay | | 〈853〉 Fluorescence Spectroscopy |
〈413〉 Impurities Testing in Medical Gases | | 〈854〉 Mid-Infrared Spectroscopy |
〈415〉 Medical Gases Assay | | 〈855〉 Nephelometry and Turbidimetry |
〈425〉 Iodometric Assay—Antibiotics | | 〈856〉 Near-Infrared Spectroscopy |
〈426〉 Histamine Test Method | | 〈857〉 Ultraviolet-Visible Spectroscopy |
〈429〉 Light Diffraction Measurement of Particle Size | | 〈858〉 Raman Spectroscopy |
〈431〉 Methoxy Determination | | 〈861〉 Sutures—Diameter |
〈432〉 Determination of Zeta Potential by Electrophoretic Light Scattering | | 〈871〉 Sutures—Needle Attachment |
〈441〉 Niacin Or Niacinamide Assay | | 〈881〉 Tensile Strength |
〈451〉 Nitrite Titration | | 〈891〉 Thermal Analysis |
〈461〉 Nitrogen Determination | | 〈905〉 Uniformity of Dosage Units |
〈466〉 Ordinary Impurities | | 〈911〉 Viscosity—Capillary Methods |
〈467〉 Residual Solvents | | 〈912〉 Viscosity—Rotational Methods |
〈469〉 Ethylene Glycol, Diethylene Glycol, and Triethylene Glycol in Ethoxylated Substances | | 〈913〉 Viscosity—Rolling Ball Method |
〈471〉 Oxygen Flask Combustion | | 〈914〉 Viscosity—Pressure Driven Methods |
〈476〉 Control of Organic Impurities in Drug Substances and Drug Products | | 〈915〉 Measurement of Structural Strength of Semisolids by Penetrometry |
〈921〉 Water Determination | | 〈1207.1〉 Package Integrity Testing in the Product Life Cycle—Test Method Selection and Validation |
〈922〉 Water Activity | | 〈1207.2〉 Package Integrity Leak Test Technologies |
〈941〉 Characterization of Crystalline and Partially Crystalline Solids By X-Ray Powder Diffraction (XRPD) | | 〈1207.3〉 Package Seal Quality Test Technologies |
〈1001〉 In Vitro Release Test Methods for Parenteral Drug Preparations | | 〈1207〉 Package Integrity Evaluation—Sterile Products |
〈1004〉 Mucosal Drug Products—Performance Tests | | 〈1208〉 Sterility Testing—Validation of Isolator Systems |
〈1005〉 Acoustic Emission | | 〈1210〉 Statistical Tools for Procedure Validation |
〈1010〉 Analytical Data—Interpretation and Treatment | | 〈1211〉 Sterility Assurance |
〈1024〉 Bovine Serum | | 〈1212〉 Probe Tack Test |
〈1025〉 Pancreatin | | 〈1216〉 Tablet Friability (1) |
〈1027〉 Flow Cytometry | | 〈1216〉 Tablet Friability |
〈1029〉 Good Documentation Guidelines | | 〈1217〉 Tablet Breaking Force |
〈1030〉 Biological Assay Chapters—Overview and Glossary | | 〈1220〉 Analytical Procedure Life Cycle |
〈1031〉 The Biocompatibility of Materials Used in Drug Containers, Medical Devices, and Implants | | 〈1222〉 Terminally Sterilized Pharmaceutical Products—Parametric Release |
〈1032〉 Design and Development of Biological Assays | | 〈1223.1〉 Validation of Alternative Methods to Antibiotic Microbial Assays |
〈1033〉 Biological Assay Validation | | 〈1223〉 Validation of Alternative Microbiological Methods |
〈1034〉 Analysis of Biological Assays | | 〈1224〉 Transfer of Analytical Procedures |
〈1039〉 Chemometrics | | 〈1225〉 Validation of Compendial Procedures |
〈1041〉 Biologics | | 〈1226〉 Verification of Compendial Procedures |
〈1042〉 Cell Banking Practices for Recombinant Biologics | | 〈1227〉 Validation of Microbial Recovery from Pharmacopeial Articles |
〈1043〉 Ancillary Materials for Cell, Gene, and Tissue-Engineered Products | | 〈1228.1〉 Dry Heat Depyrogenation |
〈1044〉 Cryopreservation of Cells | | 〈1228.3〉 Depyrogenation by Filtration |
〈1046〉 Cell-Based Advanced Therapies and Tissue-Based Products | | 〈1228.4〉 Depyrogenation by Rinsing |
〈1047〉 Gene Therapy Products | | 〈1228.5〉 Endotoxin Indicators for Depyrogenation |
〈1048〉 Quality of Biotechnological Products Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products | | 〈1228〉 Depyrogenation |
〈1049〉 Quality of Biotechnological Products Stability Testing of Biotechnological Biological Products | | 〈1229.1〉 Steam Sterilization by Direct Contact |
〈1050.1〉 Design, Evaluation, and Characterization of Viral Clearance Procedures | | 〈1229.2〉 Moist Heat Sterilization of Aqueous Liquids |
〈1050〉 Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin | | 〈1229.3〉 Monitoring of Bioburden |
〈1051〉 Cleaning Glass Apparatus | | 〈1229.4〉 Sterilizing Filtration of Liquids |
〈1052〉 Biotechnology-Derived Articles—Amino Acid Analysis | | 〈1229.5〉 Biological Indicators for Sterilization |
〈1053〉 Capillary Electrophoresis | | 〈1229.6〉 Liquid-Phase Sterilization |
〈1054〉 Biotechnology-Derived Articles—Isoelectric Focusing | | 〈1229.7〉 Gaseous Sterilization |
〈1055〉 Biotechnology-Derived Articles—Peptide Mapping | | 〈1229.8〉 Dry Heat Sterilization |
〈1056〉 Biotechnology-Derived Articles—Polyacrylamide Gel Electrophoresis | | 〈1229.9〉 Physicochemical Integrators and Indicators for Sterilization |
〈1057〉 Biotechnology-Derived Articles—Total Protein Assay | | 〈1229.10〉 Radiation Sterilization |
〈1058〉 Analytical Instrument Qualification | | 〈1229.11〉 Vapor Phase Sterilization |
〈1059〉 Excipient Performance | | 〈1229.12〉 New Sterilization Methods |
〈1061〉 Color—Instrumental Measurement | | 〈1229.13〉 Sterilization-In-Place |
〈1062〉 Tablet Compression Characterization | | 〈1229.14〉 Sterilization Cycle Development |
〈1063〉 Shear Cell Methodology for Powder Flow Testing | | 〈1229.15〉 Sterilizing Filtration of Gases |
〈1064〉 Identification of Articles of Botanical Origin by High-Performance Thin-Layer Chromatography Procedure | | 〈1229.16〉 Prion Inactivation |
〈1065〉 Ion Chromatography | | 〈1229.17〉 Mycoplasma Sterilization |
〈1066〉 Physical Environments That Promote Safe Medication Use | | 〈1229.18〉 Viral Clearance Methods |
〈1071〉 Rapid Sterility Testing of Short Life Products A Risk Based Approach | | 〈1229〉 Sterilization of Compendial Articles |
〈1072〉 Disinfectants and Antiseptics | | 〈1230〉 Water for Hemodialysis Applications |
〈1074〉 Excipient Biological Safety Evaluation Guidelines | | 〈1231〉 Water for Pharmaceutical Purposes |
〈1078〉 Good Manufacturing Practices for Bulk Pharmaceutical Excipients | | 〈1234〉 Vaccines for Human Use—Polysaccharide and Glycoconjugate Vaccines |
〈1079.1〉 Storage and Transportation of Investigational Drug Products | | 〈1235〉 Vaccines for Human Use—General Considerations |
〈1079.2〉 Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products | | 〈1236〉 Solubility Measurements |
〈1079〉 Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products | | 〈1237〉 Virology Test Methods |
〈1080〉 Bulk Pharmaceutical Excipients—Certificate of Analysis | | 〈1238〉 Vaccines for Human Use—Bacterial Vaccines |
〈1083〉 Supplier Qualification | | 〈1239〉 Vaccines for Human Use—Viral Vaccines |
〈1084〉 Glycoprotein and Glycan Analysis—General Considerations | | 〈1240〉 Virus Testing of Human Plasma for Further Manufacture |
〈1085〉 Guidelines On Endotoxins Test | | 〈1241〉 Water–Solid Interactions in Pharmaceutical Systems |
〈1086〉 Impurities in Drug Substances and Drug Products | | 〈1251〉 Weighing on an Analytical Balance |
〈1087〉 Intrinsic Dissolution—Dissolution Testing Procedures for Rotating Disk and Stationary Disk | | 〈1265〉 Written Prescription Drug Information—Guidelines |
〈1088〉 in Vitro and in Vivo Evaluation of Oral Dosage Forms | | 〈1285.1〉 Hematoxylin and Eosin Staining of Sectioned Tissue for Microscopic Examination |
〈1090〉 Assessment of Drug Product Performance—Bioavailability, Bioequivalence, and Dissolution | | 〈1285〉 Preparation of Biological Specimens for Histologic and Immunohistochemical Analysis |
〈1091〉 Labeling of Inactive Ingredients | | 〈1381〉 Assessment of Elastomeric Component Used in Injectable Pharmaceutical Product Packaging Delivery Systems |
〈1092〉 The Dissolution Procedure Development And Validation | | 〈1382〉 Assessment of Elastomeric Component Functional Suitability in Parenteral Product Packaging Delivery Systems |
〈1094〉 Capsules—Dissolution Testing and Related Quality Attributes | | 〈1430.1〉 Analytical Methodologies Based on Scattering Phenomena — Static Light Scattering |
〈1097〉 Bulk Powder Sampling Procedures | | 〈1430.2〉 Analytical Methodologies Based on Scattering Phenomena — Light Diffraction Measurements of Particle Size |
〈1099〉 Limit on Number of Large Deviations When Assessing Content Uniformity in Large Samples | | 〈1430.3〉 Analytical Methodologies Based on Scattering Phenomena—Dynamic Light Scattering |
〈1102〉 Immunological Test Methods—General Considerations | | 〈1430.4〉 Analytical Methodologies Based on Scattering Phenomena — Electrophoretic Light Scattering (Determination of Zeta Potential) |
〈1103〉 Immunological Test Methods—Enzyme-Linked Immunosorbent Assay (Elisa) | | 〈1430.5〉 Analytical Methodologies Based on Scattering Phenomena—Small Angle X-Ray Scattering and Small Angle Neutron Scattering |
〈1104〉 Immunological Test Methods—Immunoblot Analysis | | 〈1430.6〉 Analytical Methodologies Based on Scattering Phenomena—Particle Counting Via Light Scattering |
〈1105〉 Immunological Test Methods—Surface Plasmon Resonance | | 〈1430.7〉 Analytical Methodologies Based on Scattering Phenomena—Nephelometry and Turbidimetry |
〈1106.1〉 Immunogenicity Assays—Design and Validation of Assays to Detect Anti-Drug Neutralizing Antibody | | 〈1430〉 Analytical Methodologies Based on Scattering Phenomena—General |
〈1106〉 Immunogenicity Assays—Design and Validation of Immunoassays to Detect Anti-Drug Antibodies | | 〈1467〉 Residual Solvents—Verification Of Compendial Procedures And Validation Of Alternative Procedures |
〈1108〉 Assays to Evaluate Fragment Crystallizable (FC)—Mediated Effector Function | | 〈1469〉 Nitrosamine Impurities |
〈1111〉 Microbiological Examination of Nonsterile Products Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use | | 〈1503〉 Quality Attributes of Synthetic Peptide Drug Substances |
〈1112〉 Application of Water Activity Determination to Nonsterile Pharmaceutical Products | | 〈2022〉 Microbiological Procedures for Absence of Specified Microorganisms—Nutritional and Dietary Supplements |
〈1113〉 Microbial Characterization, Identification, and Strain Typing | | 〈2023〉 Microbiological Attributes of Nonsterile Nutritional and Dietary Supplements |
〈1115〉 Bioburden Control of Nonsterile Drug Substances and Products | | 〈2030〉 Supplemental Information for Articles of Botanical Origin |
〈1116〉 Microbiological Control and Monitoring of Aseptic Processing Environments | | 〈2040〉 Disintegration and Dissolution of Dietary Supplements |
〈1117〉 Microbiological Best Laboratory Practices | | 〈2091〉 Weight Variation of Dietary Supplements |
〈1118〉 Monitoring Devices—Time, Temperature, and Humidity | | 〈2232〉 Elemental Contaminants in Dietary Supplements (1) |
〈1121〉 Nomenclature | | 〈2232〉 Elemental Contaminants in Dietary Supplements |
〈1125〉 Nucleic Acid-Based Techniques—General | | 〈2250〉 Detection of Irradiated Dietary Supplements |
〈1126〉 Nucleic Acid-Based Techniques—Extraction, Detection, and Sequencing | | 〈2251〉 Screening for Undeclared Drugs and Drug Analogues |
〈1127〉 Nucleic Acid-Based Techniques—Amplification | | 〈2740〉 Manufacturing Practices For Dietary Ingredients |
〈1128〉 Nucleic Acid-Based Techniques—Microarray | | 〈2750〉 Manufacturing Practices for Dietary Supplements |
〈1129〉 Nucleic Acid-Based Techniques—Genotyping | | Alcoholometric Table |
〈1130〉 Nucleic Acid-Based Techniques—Approaches for Detecting Trace Nucleic Acids (Residual Dna Testing) | | Articles of Incorporation |
〈1132〉 Residual Host Cell Protein Measurement in Biopharmaceuticals | | Atomic Weights |
〈1149〉 Guidelines for Assessing and Controlling the Physical Stability of Chemical and Biological Pharmaceutical Raw Materials, Intermediates, and Dosage Forms | | Biotechnology-Derived Drug Products |
〈1151〉 Pharmaceutical Dosage Forms | | Biotechnology-Derived Drug Substances (1) |
〈1152〉 Animal Drugs for Use in Animal Feeds | | Biotechnology-Derived Drug Substances |
〈1153〉 Drug Products Containing Nanomaterials | | Blood and Blood Products |
〈1160〉 Pharmaceutical Calculations in Pharmacy Practice | | Chapter Charts |
〈1163〉 Quality Assurance in Pharmaceutical Compounding | | Compounding—Substance Preparation Practice |
〈1168〉 Compounding for Phase I Investigational Studies | | Containers for Dispensing Capsules and Tablets |
〈1174〉 Powder Flow | | Description and Relative Solubility (1) |
〈1176〉 Prescription Balances and Volumetric Apparatus Used in Compounding | | Description and Relative Solubility (2) |
〈1178〉 Good Repackaging Practices | | Description and Relative Solubility |
〈1180〉 Human Plasma | | Dietary Supplement Ingredients |
〈1181〉 Scanning Electron Microscopy | | Dietary Supplement Products |
〈1184〉 Sensitization Testing | | Drug Product Distribution |
〈1191〉 Stability Considerations in Dispensing Practice | | Excipients |
〈1195〉 Significant Change for Bulk Pharmaceutical Excipients | | Gene and Cell Therapy Products |
〈1197〉 Good Distribution Practices for Bulk Pharmaceutical Excipients | | General Information |
General Notices and Requirements | | Non-Complex Drug Substances |
Half-Lives of Selected Radionuclides | | Notice and Warning |
Intrinsic Viscosity Table | | Six-Month Implementation Guideline |
Medical Devices | | Solubilities |
Microbiology Products | | USP Admissions List (1) |
Mission and Preface | | USP Admissions List (2) |
NF Admissions List (1) | | USP Admissions List |
NF Admissions List | | USP Annotated List (1) |
NF Annotated List (1) | | USP Annotated List (2) |
NF Annotated List (2) | | USP Annotated List |
NF Annotated List | | Vaccines |
Non-Complex Active Drug Products | | |
5-Hydroxy-l-tryptophan | Acetohydroxamic Acid Tablets | |
Abacavir and Lamivudine Tablets | Acetohydroxamic Acid | |
Abacavir Oral Solution | Acetone | |
Abacavir Sulfate | Acetylcholine Chloride for Ophthalmic Solution | |
Abacavir Tablets | Acetylcholine Chloride | |
Abacavir, Lamivudine and Zidovudine Tablets | Acetylcysteine Compounded Solution | |
Abiraterone Acetate Tablets | Acetylcysteine Solution | |
Abiraterone Acetate | Acetylcysteine | |
Absorbable Gelatin Film | Acetyltributyl Citrate | |
Absorbable Gelatin Sponge | Acetyltriethyl Citrate | |
Absorbable Surgical Suture | Acitretin Capsules | |
Absorbent Gauze | Acitretin | |
Acacia Syrup | Activated Attapulgite | |
Acacia | Activated Charcoal | |
Acamprosate Calcium | Acyclovir Capsules | |
Acarbose Tablets | Acyclovir for Injection | |
Acarbose | Acyclovir Injection | |
Acebutolol Hydrochloride Capsules | Acyclovir Ointment | |
Acebutolol Hydrochloride | Acyclovir Oral Suspension | |
Acepromazine Maleate Injection | Acyclovir Tablets | |
Acepromazine Maleate Tablets | Acyclovir | |
Acepromazine Maleate | Adapalene Gel | |
Acesulfame Potassium | Adapalene | |
Acetaminophen and Aspirin Tablets | Adenine | |
Acetaminophen and Caffeine Tablets | Adenosine Injection | |
Acetaminophen and Codeine Phosphate Capsules | Adenosine | |
Acetaminophen and Codeine Phosphate Oral Solution | Adhesive Bandage | |
Acetaminophen and Codeine Phosphate Oral Suspension | Adhesive Tape | |
Acetaminophen and Codeine Phosphate Tablets | Adipic Acid | |
Acetaminophen and Diphenhydramine Citrate Tablets | Agar | |
Acetaminophen and Pseudoephedrine Hydrochloride Tablets | Alanine | |
Acetaminophen Capsules | Albendazole Oral Suspension | |
Acetaminophen Extended-Release Tablets | Albendazole Tablets | |
Acetaminophen for Effervescent Oral Solution | Albendazole | |
Acetaminophen Oral Solution | Albumin Human | |
Acetaminophen Oral Suspension | Albuterol Extended-Release Tablets | |
Acetaminophen Suppositories | Albuterol Inhalation Solution | |
Acetaminophen Tablets | Albuterol Sulfate | |
Acetaminophen, Aspirin, and Caffeine Tablets | Albuterol Tablets | |
Acetaminophen, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide Tablets | Albuterol | |
Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, and Pseudoephedrine Hydrochloride Oral Solution | Alclometasone Dipropionate Cream | |
Acetaminophen, Diphenhydramine Hydrochloride, and Pseudoephedrine Hydrochloride Tablets | Alclometasone Dipropionate Ointment | |
Acetaminophen | Alclometasone Dipropionate | |
Acetazolamide Compounded Oral Suspension | Alcohol | |
Acetazolamide for Injection | Alendronate Sodium Tablets | |
Acetazolamide Tablets | Alendronate Sodium | |
Acetazolamide | Alfadex | |
Acetic Acid Irrigation | Alfentanil Hydrochloride | |
Acetic Acid Otic Solution | Alfentanil Injection | |
Acetic Acid | Alfuzosin Hydrochloride Extended-Release Tablets | |
Alfuzosin Hydrochloride | Aluminum Dichlorohydrex Propylene Glycol | |
Alginic Acid | Aluminum Hydroxide Gel | |
Alkyl (C12–15) Benzoate | Aluminum Monostearate | |
Allantoin | Aluminum Oxide | |
Allopurinol Compounded Oral Suspension | Aluminum Phosphate Gel | |
Allopurinol Tablets | Aluminum Sesquichlorohydrate Solution | |
Allopurinol | Aluminum Sesquichlorohydrate | |
Allyl Isothiocyanate | Aluminum Sesquichlorohydrex Polyethylene Glycol | |
Almond Oil | Aluminum Sesquichlorohydrex Propylene Glycol | |
Almotriptan Malate | Aluminum Subacetate Topical Solution | |
Almotriptan Tablets | Aluminum Sulfate and Calcium Acetate for Topical Solution | |
Aloe | Aluminum Sulfate and Calcium Acetate Tablets for Topical Solution | |
Alosetron Hydrochloride | Aluminum Sulfate | |
Alosetron Tablets | Aluminum Zirconium Octachlorohydrate Solution | |
Alpha Lipoic Acid Capsules | Aluminum Zirconium Octachlorohydrate | |
Alpha Lipoic Acid Tablets | Aluminum Zirconium Octachlorohydrex Gly Solution | |
Alpha Lipoic Acid | Aluminum Zirconium Octachlorohydrex Gly | |
Alpha-Lactalbumin | Aluminum Zirconium Pentachlorohydrate Solution | |
Alprazolam Compounded Oral Suspension | Aluminum Zirconium Pentachlorohydrate | |
Alprazolam Extended-Release Tablets | Aluminum Zirconium Pentachlorohydrex Gly Solution | |
Alprazolam Orally Disintegrating Tablets | Aluminum Zirconium Pentachlorohydrex Gly | |
Alprazolam Tablets | Aluminum Zirconium Tetrachlorohydrate Solution | |
Alprazolam | Aluminum Zirconium Tetrachlorohydrate | |
Alprostadil Injection | Aluminum Zirconium Tetrachlorohydrex Gly Solution | |
Alprostadil | Aluminum Zirconium Tetrachlorohydrex Gly | |
Alteplase for Injection | Aluminum Zirconium Trichlorohydrate Solution | |
Alteplase | Amantadine Hydrochloride Capsules | |
Altretamine Capsules | Amantadine Hydrochloride Oral Solution | |
Altretamine | Amantadine Hydrochloride Tablets | |
Alumina and Magnesia Oral Suspension | Amantadine Hydrochloride | |
Alumina and Magnesia Tablets | Amcinonide Cream | |
Alumina and Magnesium Carbonate Oral Suspension | Amcinonide Ointment | |
Alumina and Magnesium Carbonate Tablets | Amcinonide | |
Alumina and Magnesium Trisilicate Oral Suspension | American Ginseng Capsules | |
Alumina and Magnesium Trisilicate Tablets | American Ginseng Root and Rhizome Dry Extract | |
Alumina, Magnesia, and Calcium Carbonate Chewable Tablets | American Ginseng Root and Rhizome Powder | |
Alumina, Magnesia, and Calcium Carbonate Oral Suspension | American Ginseng Root and Rhizome | |
Alumina, Magnesia, and Simethicone Chewable Tablets | American Ginseng Tablets | |
Alumina, Magnesia, and Simethicone Oral Suspension | Amifostine for Injection | |
Alumina, Magnesia, Calcium Carbonate, and Simethicone Chewable Tablets | Amifostine | |
Alumina, Magnesium Carbonate, and Magnesium Oxide Tablets | Amikacin Sulfate Injection | |
Aluminum Acetate Topical Solution | Amikacin Sulfate | |
Aluminum Chloride | Amikacin | |
Aluminum Chlorohydrate Solution | Amiloride Hydrochloride and Hydrochlorothiazide Tablets | |
Aluminum Chlorohydrate | Amiloride Hydrochloride Tablets | |
Aluminum Chlorohydrex Polyethylene Glycol | Amiloride Hydrochloride | |
Aluminum Chlorohydrex Propylene Glycol | Amiloxate | |
Aluminum Dichlorohydrate Solution | Amino Methacrylate Copolymer | |
Aluminum Dichlorohydrate | Aminobenzoate Potassium Capsules | |
Aluminum Dichlorohydrex Polyethylene Glycol | Aminobenzoate Potassium | |
Aminobenzoate Sodium | Ammonium Sulfate | |
Aminobenzoic Acid Gel | Amobarbital Sodium for Injection | |
Aminobenzoic Acid | Amobarbital Sodium | |
Aminocaproic Acid Injection | Amodiaquine Hydrochloride Tablets | |
Aminocaproic Acid Oral Solution | Amodiaquine Hydrochloride | |
Aminocaproic Acid Tablets | Amodiaquine | |
Aminocaproic Acid | Amoxapine Tablets | |
Aminohippurate Sodium Injection | Amoxapine | |
Aminohippuric Acid | Amoxicillin and Clavulanate Potassium for Oral Suspension | |
Aminolevulinic Acid Hydrochloride | Amoxicillin and Clavulanate Potassium Tablets | |
Aminopentamide Sulfate Injection | Amoxicillin and Clavulanic Acid Extended-Release Tablets | |
Aminopentamide Sulfate Tablets | Amoxicillin Boluses | |
Aminopentamide Sulfate | Amoxicillin Capsules | |
Aminophylline Delayed-Release Tablets | Amoxicillin for Injectable Suspension | |
Aminophylline Injection |